AC Immune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.

About ACIU

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. 

CEO
Martin Zügel
CEOMartin Zügel
Employees
122
Employees122
Headquarters
Lausanne, Vaud
HeadquartersLausanne, Vaud
Founded
2003
Founded2003
Employees
122
Employees122

ACIU Key Statistics

Market cap
236.12M
Market cap236.12M
Price-Earnings ratio
-2.82
Price-Earnings ratio-2.82
Dividend yield
Dividend yield
Average volume
393.88K
Average volume393.88K
High today
$2.29
High today$2.29
Low today
$2.29
Low today$2.29
Open price
$2.28
Open price$2.28
Volume
293.00
Volume293.00
52 Week high
$4.00
52 Week high$4.00
52 Week low
$1.65
52 Week low$1.65

Stock Snapshot

AC Immune(ACIU) stock is priced at $2.29, giving the company a market capitalization of 236.12M. It carries a P/E multiple of -2.82.

During the trading session on 2026-06-15, AC Immune(ACIU) shares reached a daily high of $2.29 and a low of $2.29. At a current price of $2.29, the stock is 0.0% higher than the low and still 0.0% under the high.

Trading activity shows a volume of 293, compared to an average daily volume of 393.88K.

The stock's 52-week range extends from a low of $1.65 to a high of $4.00.

The stock's 52-week range extends from a low of $1.65 to a high of $4.00.

ACIU News

TipRanks 4d
AC Immune Shareholders Back Capital Band, Governance Slate and Pay Caps at June 11 AGM

AC Immune SA ( (ACIU) ) has shared an announcement. On June 11, 2026, AC Immune SA held its Annual General Meeting, where shareholders approved the company’s 2...

TipRanks 4d
AC Immune Secures $4 Million Goradia Foundation Grant to Extend Phase 2 Parkinson’s Trial

AC Immune SA ( (ACIU) ) has shared an announcement. On June 11, 2026, AC Immune SA said it will receive a $4 million research grant from The Vijay and Marie Go...

People also own

Based on the portfolios of people who own ACIU. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.